Skip to main content

 News

Choosing to participate in a clinical trial

Press release (21/02/2019)  Choosing to participate in a clinical trial
The Jules Bordet Institute launches an interactive tool to support cancer patients in making their choices Thursday 21/02/2019 – Should I participate in this clinical trial? That is the question many patients have to ask themselves during their cancer treatment. With several hundred clinical trials launched every year, cancer patients have…
(read more)

Exclusive images of the new Jules Bordet Institute!

Watch the video and discover the major project for the new Jules Bordet Institute, a European reference centre in the fight against cancer. Magnificent images of the construction work on the   80,000 m² dedicated exclusively to cancer are accompanied by explanations on how the project was conceived to combine excellence of patient care with optimal well-being for patients and care staff.
.... In short version! 
(read more)

20ème Journée Annuelle d'Oncologie Thoracique

Samedi 30 mars 2019 20ème Journée Annuelle d'Oncologie Thoracique Le traitement du cancer bronchique : quels progrès en pratique en 20 ans? En une vingtaine d’année, l’abord thérapeutique du cancer bronchique a bénéficié de nombreux progrès, avec une accélération toute récente avec l’introduction des nouvelles immunothérapies. Il nous a dès lors semblé approprié de prendre pour thème de cette 20ème édition de la Journée Annuelle d’…
(read more)

Pancreatic cancer finally better known!

Press release (10/12/2018)  Researchers at the Jules Bordet Institute and the Erasmus Hospital identify five subtypes of pancreatic cancer. 10/12/2018 - With more than 1500 new cases detected in Belgium every year, pancreatic cancer today kills nearly all those who develop the disease. An alarming figure that is a driving force behind researchers and in particular for Doctor Francesco Puleo, gastroenterologist at the Digestive…
(read more)

Actualités en Médecine Factuelle

Saterday 23/02/2019 Actualités en médecine factuelle Université Libre de Bruxelles - Institut Bordet   Presidency : Hervé Maisonneuve (Lyon) & Michel Vanhaeverbeek (ULB) Avec l’introduction d’un enseignement transversal intégrant la médecine factuelle dans la réforme des études de médecine en 6 ans et le cours de médecine factuelle organisé tous les ans pendant les masters de spécialité, le troisième pilier de l’…
(read more)

2018 Bob Pinedo Cancer Care Award

Press release (23/11/2018)  Professor Martine Piccart receives the 2018 Bob Pinedo Cancer Care Award in the Netherlands. 23/11/2018 - This 22 November, Professor Martine Piccart, Director of Scientific Research at the Jules Bordet Institute, received the 2018 Bob Pinedo Cancer Care Award from the Royal Netherlands Academy of Sciences. This award is in recognition of her major scientific contribution in the field of breast cancer, its…
(read more)

Breast Cancer Debate of the Year” and the “Best of SABCSR 2018” symposia

25/01/2019 and 26/01/2019 Breast Cancer Debate of the Year” and the “Best of SABCSR 2018” symposia THE HOTEL - Grand Ballroom 1st Floor
Boulevard de Waterloo 38, 1000 Brussels Dear Colleagues of the Oncology Community, Dear BSMO members,
On behalf of the Belgian Society of Medical Oncology (BSMO) represented by its Breast Cancer Task Force and the Institute Jules Bordet, we would like to take the opportunity to invite you to…
(read more)

Christmas market

from 01/12 to 07/12/2018 Christmas market at the Jules Bordet Institute Sale of delicacies and handicrafts!
Evey afternoon  Come and visit the restaurant on the ground floor, it's for the good cause! All profits will be donated to the Friends of the Bordet Institute and the Nursing Fund for the well-being of patients.
(read more)

World HTLV Day (10/11/2018)

10/11/2018 «World HTLV Day»  10 November: raising awareness of HTLV-1 Several research teams worldwide are working to raise awareness of an under-researched virus, Human T cell Leukemia Virus type 1 (HTLV-1) and find better treatments for the devastating illnesses that it causes. Among them, Anne Van den Broeke’s team at the Institut Jules Bordet. HTLV-1 a cousin of HIV The catastrophic impact of HIV - Human Immunodeficiency Virus,…
(read more)